Search
Abeona Therapeutics Inc
ABEOAdd to Watchlist
5.430USD
-0.100-1.81%
Close 09-24 16:00（ET）
309.51MMarket Cap
4.24P/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
-1.81%
5 Days
-2.86%
1 Month
-10.40%
6 Months
+25.40%
Year to Date
+3.04%
1 Year
-2.16%
Key Figures
5.590Open
5.590High
73.62KVolume
4.24P/E TTM
LossP/E Dynamic
--Dividend TTM
0.13%Turnover Ratio
5.530Prev. Close
5.380Low
400.61KTurnover
LossP/E Static
2.42P/B
0.00%Div Yield TTM
44.41%ROA
7.65052wk High
15.18Volume Ratio
-63.73MNet Profit
57.00MShares
1.2844EPS TTM
1.34Beta
70.99%ROE
4.00052wk Low
9.31%Amplitude
65.81%Gross Margin
309.51MMarket Cap
-2.52Reward/Risk
3.34%Risk Rate
Abeona Therapeutics Inc's Score
-0.04vs previous score
Forecast8.86
Financial Health8.69
Technical3.58
Valuation Dimensions7.44
Institutional Confidence7.00
Risk Assessment5.60
Media Coverage
Coverage Level
Very Low
Very High
No data
Analyst Rating
Abeona Therapeutics Inc Technical Analysis
Technical Indicators
Strong sell
Summary
Sell
Moving Average
Strong sell
Abeona Therapeutics Inc Latest Earnings Call Transcripts
Abeona Therapeutics (ABEO) Q2 2026 Earnings Call: ZEVASKYN Revenue Rises 31%
Abeona Therapeutics (ABEO) Q2 2026 earnings call: ZEVASKYN revenue rose 31% QoQ to $11.4M, seven QTCs were active, and cash totaled $146.8M.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.35/-0.23
Revenue / Forecast
11.38M/12.24M
Abeona Therapeutics Inc Profile
SectorPharmaceuticals
Ticker SymbolABEO
Number of employees136
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Nantahala Capital Management, LLC | 8.73% |
| Cable Car Capital LLC | 5.29% |
| Kaufman Kapital LLC | 5.17% |
| BlackRock Institutional Trust Company, N.A. | 5.09% |
| Shareholder Types | Proportion |
|---|---|
| Hedge Fund | 22.33% |
| Investment Advisor | 19.81% |
| Investment Advisor/Hedge Fund | 16.13% |
| Corporation | 9.96% |
Related Instruments
+2.68%
+0.56%
+0.02%
-0.07%
+0.60%
+0.75%
-0.01%
-1.11%
+1.18%
+0.82%
+1.17%
+0.57%
-1.27%
-0.12%
-1.73%
-0.72%
+6.98%
+1.73%
-1.17%
+0.61%
FAQs
What is the current price of Abeona Therapeutics Inc (ABEO)?
The current price of Abeona Therapeutics Inc (ABEO) is 5.43.
What is the symbol of Abeona Therapeutics Inc?
The ticker symbol of Abeona Therapeutics Inc is ABEO.
What is the 52-week high of Abeona Therapeutics Inc?
The 52-week high of Abeona Therapeutics Inc is 7.65.
What is the 52-week low of Abeona Therapeutics Inc?
The 52-week low of Abeona Therapeutics Inc is 4.00.
What is the market capitalization of Abeona Therapeutics Inc?
The market capitalization of Abeona Therapeutics Inc is 309.51M.
Is Abeona Therapeutics Inc (ABEO) currently rated as Buy, Hold, or Sell?
According to analysts, Abeona Therapeutics Inc (ABEO) has an overall rating of Buy, with a price target of 18.88.
What is the Earnings Per Share (EPS TTM) of Abeona Therapeutics Inc (ABEO)?
The Earnings Per Share (EPS TTM) of Abeona Therapeutics Inc (ABEO) is 1.28.